Compare ADPT & AMBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ADPT | AMBP |
|---|---|---|
| Founded | 2009 | 2021 |
| Country | United States | Luxembourg |
| Employees | N/A | 6500 |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Containers/Packaging |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 2.4B |
| IPO Year | 2019 | N/A |
| Metric | ADPT | AMBP |
|---|---|---|
| Price | $17.07 | $4.05 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 9 | 7 |
| Target Price | ★ $17.78 | $4.39 |
| AVG Volume (30 Days) | ★ 1.7M | 1.3M |
| Earning Date | 05-05-2026 | 04-23-2026 |
| Dividend Yield | N/A | ★ 10.39% |
| EPS Growth | ★ 63.89 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $276,976,000.00 | N/A |
| Revenue This Year | $3.98 | $7.31 |
| Revenue Next Year | $22.72 | $2.53 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 54.77 | N/A |
| 52 Week Low | $9.96 | $3.29 |
| 52 Week High | $20.76 | $5.03 |
| Indicator | ADPT | AMBP |
|---|---|---|
| Relative Strength Index (RSI) | 66.43 | 54.03 |
| Support Level | $14.87 | $3.84 |
| Resistance Level | $17.52 | $4.28 |
| Average True Range (ATR) | 0.93 | 0.11 |
| MACD | 0.33 | 0.00 |
| Stochastic Oscillator | 81.33 | 50.00 |
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers. The company has two operating segments: Minimal Residual Disease and Immune Medicine. The company generates the majority of its revenue from the Minimal Residual Disease segment.
Ardagh Metal Packaging SA is a supplier of infinitely recyclable, sustainable, metal beverage cans and ends to brand owners. The company deals with multiple categories of products including beer, carbonated soft drinks, energy drinks, hard seltzers, juices, pre-mixed cocktails, teas, sparkling waters, and wine. The geographical segments of the company includes Europe and the Americas. Geographically, the company derives a majority of its revenue from the United States.